Other specified parasitic diseases
ICD-10 B53 is a billable code used to indicate a diagnosis of other specified parasitic diseases.
ICD-10 code B53 encompasses a range of parasitic diseases that do not fall under more specific categories. One of the most significant diseases included in this code is malaria, which is caused by Plasmodium species, including P. falciparum, P. vivax, P. ovale, and P. malariae. Malaria is transmitted through the bite of infected Anopheles mosquitoes and is characterized by symptoms such as fever, chills, and flu-like illness. The identification of the specific Plasmodium species is crucial for determining the appropriate treatment and understanding the potential for antimalarial resistance, which is a growing concern in many endemic areas. Prophylaxis against malaria is also an important aspect of management, particularly for travelers to endemic regions, and involves the use of antimalarial medications such as atovaquone-proguanil, doxycycline, or mefloquine. Accurate coding for malaria and other parasitic diseases requires thorough documentation of the species involved, any resistance patterns, and the prophylactic measures taken, as these factors significantly influence treatment decisions and patient outcomes.
Detailed patient history, including travel and exposure history, laboratory results for species identification, and treatment plans.
Diagnosis and management of malaria, evaluation of antimalarial resistance, and treatment of co-infections.
Ensure accurate documentation of species and resistance to guide treatment decisions.
Comprehensive travel history, prophylaxis recommendations, and follow-up care documentation.
Pre-travel consultations, post-travel evaluations, and management of travelers' diarrhea or malaria.
Focus on preventive measures and education regarding malaria prophylaxis.
Used for rapid diagnosis of malaria in patients presenting with fever.
Document the reason for testing and results.
Infectious disease specialists should ensure accurate interpretation of results.
Coding for specific Plasmodium species is crucial for determining the appropriate treatment and understanding potential resistance patterns, which can significantly impact patient outcomes.
